• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统研究不同药物纳米晶体技术制备快速溶解美洛昔康片

Systematical Investigation of Different Drug Nanocrystal Technologies to Produce Fast Dissolving Meloxicam Tablets.

机构信息

Department of Pharmaceutical Engineering, Qingdao University of Science and Technology, Qingdao, China.

Department of Internal Medicine, Qingdao Shibei District People Hospital, Qingdao, China.

出版信息

AAPS PharmSciTech. 2018 Feb;19(2):783-791. doi: 10.1208/s12249-017-0889-8. Epub 2017 Oct 10.

DOI:10.1208/s12249-017-0889-8
PMID:29019059
Abstract

Three different methods, i.e., high-pressure homogenization, wet bead milling, and a combination approach of freeze-drying and high-pressure homogenization, were used to produce meloxicam nanosuspensions, respectively. Wet bead milling led to the nanosuspensions with smallest particle size (88 nm) after 4 h and optimal dissolution performances. Freeze-dried meloxicam powder could highly improve the size reduction efficiency compared to the unmodified drug and particle size of the freeze-dried sample could be reduced to 342 nm after only one homogenization cycle at 1000 bar. The polymorphism transition and change of the particle morphology after the lyophilization might be important reasons to affect the nanosizing processes. Interestingly, the tablets prepared by using nanosuspensions from homogenizer and combination process showed faster dissolution in the first 20 min than the bead milling nanocrystal tablets.

摘要

分别采用高压匀浆法、湿磨法和冷冻干燥-高压匀浆相结合的方法制备美洛昔康纳米混悬剂。湿磨法在 4 小时后得到了最小粒径(88nm)和最佳溶解性能的纳米混悬剂。与未修饰的药物相比,冻干美洛昔康粉末可以大大提高粒径减小的效率,并且在仅经过 1000 巴的 1 个高压匀浆循环后,冻干样品的粒径可以减小至 342nm。冷冻干燥后多晶型转变和颗粒形态的变化可能是影响纳米化过程的重要原因。有趣的是,使用高压匀浆和组合工艺制备的纳米混悬剂制备的片剂在前 20 分钟内显示出比珠磨法制备的纳米晶片剂更快的溶解速度。

相似文献

1
Systematical Investigation of Different Drug Nanocrystal Technologies to Produce Fast Dissolving Meloxicam Tablets.系统研究不同药物纳米晶体技术制备快速溶解美洛昔康片
AAPS PharmSciTech. 2018 Feb;19(2):783-791. doi: 10.1208/s12249-017-0889-8. Epub 2017 Oct 10.
2
Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.应用组合粒径减小技术 H 42 生产速溶格列本脲片。
Eur J Pharm Sci. 2013 Jul 16;49(4):565-77. doi: 10.1016/j.ejps.2013.04.003. Epub 2013 Apr 12.
3
Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach.采用质量源于设计(QbD)方法开发含美洛昔康纳米晶体的口服冻干制剂。
Eur J Pharm Sci. 2017 Jun 15;104:356-365. doi: 10.1016/j.ejps.2017.04.011. Epub 2017 Apr 20.
4
Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.研究改善难溶性美洛昔康溶解性能的制备参数。
Int J Pharm. 2009 Nov 3;381(2):153-9. doi: 10.1016/j.ijpharm.2009.07.009. Epub 2009 Jul 17.
5
Study of Top-down and Bottom-up Approaches by Using Design of Experiment (DoE) to Produce Meloxicam Nanocrystal Capsules.采用实验设计(DoE)研究自上而下和自下而上方法制备美洛昔康纳米晶胶囊。
AAPS PharmSciTech. 2020 Jan 23;21(3):79. doi: 10.1208/s12249-020-1621-7.
6
Production of drug nanosuspensions: effect of drug physical properties on nanosizing efficiency.药物纳米混悬液的制备:药物物理性质对纳米化效率的影响。
Drug Dev Ind Pharm. 2018 Feb;44(2):233-242. doi: 10.1080/03639045.2017.1386207. Epub 2017 Oct 17.
7
Performance comparison of two novel combinative particle-size-reduction technologies.两种新型组合粒径减小技术的性能比较。
J Pharm Sci. 2013 May;102(5):1636-49. doi: 10.1002/jps.23475. Epub 2013 Feb 21.
8
Active freeze drying for production of nanocrystal-based powder: A pilot study.活性冷冻干燥法生产基于纳米晶体的粉末:一项初步研究。
Int J Pharm. 2018 Jan 30;536(1):222-230. doi: 10.1016/j.ijpharm.2017.11.050. Epub 2017 Nov 23.
9
A novel high-pressure precipitation tandem homogenization technology for drug nanocrystals production - a case study with ursodeoxycholic acid.一种新型高压沉淀串联匀化技术用于药物纳米晶体的生产——以熊去氧胆酸为例。
Pharm Dev Technol. 2014 Sep;19(6):662-70. doi: 10.3109/10837450.2013.819015. Epub 2013 Jul 22.
10
Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches.纳米晶体:新型组合方法与传统自上而下方法在粒径减小效果方面的比较。
Eur J Pharm Biopharm. 2012 May;81(1):82-90. doi: 10.1016/j.ejpb.2011.12.015. Epub 2012 Jan 2.

引用本文的文献

1
Nano-enabled agglomerates and compact: Design aspects of challenges.纳米团聚体与致密体:挑战的设计方面
Asian J Pharm Sci. 2023 Mar;18(2):100794. doi: 10.1016/j.ajps.2023.100794. Epub 2023 Feb 23.
2
A comprehensive analysis of meloxicam particles produced by nanosecond laser ablation as a wet milling technique.纳秒激光烧蚀法制备美洛昔康颗粒的综合分析:一种湿磨技术。
Sci Rep. 2022 Jul 22;12(1):12551. doi: 10.1038/s41598-022-16728-9.
3
Using Amphiphilic Polymer Micelles as the Templates of Antisolvent Crystallization to Produce Drug Nanocrystals.
以两亲性聚合物胶束作为抗溶剂结晶模板制备药物纳米晶体。
ACS Omega. 2022 Jun 7;7(24):21000-21013. doi: 10.1021/acsomega.2c01792. eCollection 2022 Jun 21.
4
Advancement of nanomedicines in chronic inflammatory disorders.纳米医学在慢性炎症性疾病中的进展。
Inflammopharmacology. 2022 Apr;30(2):355-368. doi: 10.1007/s10787-022-00927-x. Epub 2022 Feb 25.
5
Nanocrystals based pulmonary inhalation delivery system: advance and challenge.基于纳米晶体的肺部吸入给药系统:进展与挑战。
Drug Deliv. 2022 Dec;29(1):637-651. doi: 10.1080/10717544.2022.2039809.
6
Advanced modification of drug nanocrystals by using novel fabrication and downstream approaches for tailor-made drug delivery.通过使用新颖的制备和下游方法对药物纳米晶体进行高级修饰,以实现定制药物传递。
Drug Deliv. 2019 Dec;26(1):1092-1103. doi: 10.1080/10717544.2019.1682721.